The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2026

Filed:

Apr. 17, 2023
Applicant:

Luna Health, Inc., Wilmington, DE (US);

Inventors:

Per John Sjolund, San Diego, CA (US);

Sean Thomas Saint, San Diego, CA (US);

Jack David Pryor, San Diego, CA (US);

Lane Desborough, Thousand Oaks, CA (US);

Assignee:

Luna Health, Inc., Wilmington, DE (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/142 (2006.01); G16H 20/17 (2018.01); G16H 40/67 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61M 5/14244 (2013.01); G16H 20/17 (2018.01); G16H 40/67 (2018.01); A61M 2005/14208 (2013.01); A61M 2202/0486 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01);
Abstract

An insulin management method is provided. The method includes providing an insulin delivery device, wherein the insulin delivery device is in the form of an automatic insulin delivery device attachable to a user's body for the duration of a fasting period. The method includes delivering insulin from the insulin delivery device during the fasting period within an overall time period in the form of correction bolus doses of insulin in response to received blood glucose measurements. The insulin delivery device refrains from administering basal insulin at a preset or default rate or in a preset or default pattern. Insulin is received by the user from a non-fasting insulin management modality during a non-fasting period within the overall time period and the non-fasting insulin management modality provides at least one of a basal dose of insulin and bolus doses of insulin. Other methods, devices and systems are also provided.


Find Patent Forward Citations

Sjolund, Per. (2026). Systems, devices and related methods of coordinating insulin management and delivery modes in fasting and non-fasting periods (U.S. Patent No. 12766260). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12766260

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…